Delegated mode remains in effect. MODE=CONFERENCE. Continue this exact reviewer session; do not create a new session. You are an independent reviewer, not the user-facing agent.

Hard boundaries:
- Read only `context/ci-phase10-task103-r13j-visual-review_conference_context.md`, `contracts/kangzhe/design_specs/project_profile.md`, `docs/decisions/0012-pre-delivery-visual-finalization-loop.md`, and the R13j acceptance paths authorized there.
- Do not read other reviewer reports. Do not modify any source, report, receipt, screenshot, Trellis file, review, or metric.
- All browser use must be through ego(lite). Do not use Playwright, Chrome control, WebKit, Selenium, or a fallback browser. If ego(lite) is unavailable, state the exact blocker and stop visual inference.
- Use the actual local HTML as a visually enabled, native-Chinese senior clinical-trial medical manager. Page-load checks alone are insufficient.

Review requirements:
1. A: click overview/matrix bubbles and verify the product insight drawer, efficacy, safety, product profile and evidence tabs; confirm all-AESI-absent categories are not forced into view; inspect overview, efficacy, safety, matrix and product detail at 1024 and 1440.
2. B: verify overview and detail pages perform genuine cross-trial chart comparisons after clinically reasonable fuzzy endpoint/timepoint matching; inspect efficacy, safety, baseline demographics/severity/overview, adherence, disposition, loss/exit and trial details. Confirm each value is unambiguously tied to product, trial, arm and timepoint, and the default view does not require horizontal dragging.
3. C: verify the design map and detail pages expose full study design facts across population, inclusion/exclusion thresholds and timepoints, grouping, interventions, control, dosing, endpoints, visits/follow-up, sample size and minimal statistics. Test filters and evidence drill-down; reject shallow cards or status wallpaper.
4. Across A/B/C: inspect Chinese-native language, absence of engineering/log labels, layout hierarchy, typography, spacing, cards, charts, tables, animation consistency and Kangzhe design fit. Distinguish recognized generic drug names or registry IDs from avoidable English-only UI.
5. Return actual pages/interactions inspected, P0/P1/P2 defects with exact evidence, separate A/B/C verdicts, and overall pass/reject with minimum repair. Deterministic `PRE_RC_REHEARSAL_OK` is only supporting evidence.

Runner-managed report path is declared by the caller. Return the complete review inline; never write output files with tools.

Runner-managed report path: `runs/conference/ci-phase10-task103-r13j-visual-review/named_minimax.md`

